Longevity Impact Fund
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
The evidence directly references 'Funding Translational Longevity Research.' OpenDrugs is positioned at the longevity research tooling and evidence layer, making this a relevant specialist capital target for a science-first platform.